Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Roughly 85 percent of people will develop a rash with sufficient urushiol exposure
doi:10.2337/db06-0006 113
Given the promising anti-cancer effects of IGF-IR-targeted agents in preclinical models, clinical trials have been initiated to evaluate the efficacy of anti-IGF-IR mAbs (Table 1) [144,145,146,147,148,149,150,151]
A 2023 stability study published in Peptide Science tested AHK-Cu stability under various storage conditions using HPLC-MS to measure copper-peptide complex integrity
US$ 23.71
US$ 29.97
US$ 25.02
.jpg)
US$ 27.41
US$ 23.46
